RecruitingNCT07224906
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart
Sponsor
HemoCept Inc.
Enrollment
50 participants
Start Date
Dec 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
- Subjects can be any gender but must be age 18 or older.
- Subject is able and willing to provide informed consent and HIPAA authorization.
- Subject is able and willing to meet all study requirements.
- Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)
Exclusion Criteria1
- Subject is pregnant, breastfeeding, or intends to become pregnant during this study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07224906
Related Trials
Development of Novel Physiological CMR Methods in Health and Disease
NCT038540711 location
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
NCT0707382036 locations
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
NCT074771971 location
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
NCT017300921 location
Preliminary Human Trials of F230 Tablets
NCT068998151 location